Ingalls Kerry D.
- SEC CIK
- 0001816804
No open-market purchases or sales filed in the past year.
Current role at each company
- PSTX Poseida Therapeutics, Inc.Chief Operating Officeras of Mar 18, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ingalls Kerry D. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2022 (view filing) | Mar 16 | 2 days | Ingalls Kerry D.Chief Operating Officer | PPurchase | +3.00K | $3.98 | +$11.9K | +5.8%55.0K after | |
| Nov 18, 2021 (view filing) | Nov 17 | 1 day | Ingalls Kerry D.Chief Operating Officer | PPurchase | +2.00K | $7.00 | +$14.0K | New position2.00K after |